ACCENDRA HEALTH INC (ACH) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ACH • US6907321029

2.32 USD
+0.06 (+2.65%)
At close: Feb 4, 2026
2.32 USD
0 (0%)
After Hours: 2/4/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, ACH scores 3 out of 10 in our fundamental rating. ACH was compared to 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACH while its profitability can be described as average. ACH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ACH had positive earnings in the past year.
  • In the past year ACH has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ACH reported negative net income in multiple years.
  • In the past 5 years ACH always reported a positive cash flow from operatings.
ACH Yearly Net Income VS EBIT VS OCF VS FCFACH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

  • ACH's Return On Assets of -33.21% is on the low side compared to the rest of the industry. ACH is outperformed by 84.31% of its industry peers.
  • With an excellent Return On Invested Capital value of 10.36%, ACH belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ACH is below the industry average of 9.16%.
  • The last Return On Invested Capital (10.36%) for ACH is above the 3 year average (6.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROIC 10.36%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ACH Yearly ROA, ROE, ROICACH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

  • ACH has a Operating Margin (3.07%) which is in line with its industry peers.
  • ACH's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 26.13%, ACH perfoms like the industry average, outperforming 53.92% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACH has grown nicely.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 26.13%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
ACH Yearly Profit, Operating, Gross MarginsACH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ACH is creating some value.
  • ACH has more shares outstanding than it did 1 year ago.
  • ACH has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ACH has an improved debt to assets ratio.
ACH Yearly Shares OutstandingACH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ACH Yearly Total Debt VS Total AssetsACH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.40, we must say that ACH is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.40, ACH is doing worse than 60.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACC1.59
WACC6.5%
ACH Yearly LT Debt VS Equity VS FCFACH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that ACH may have some problems paying its short term obligations.
  • ACH has a worse Current ratio (0.86) than 78.43% of its industry peers.
  • ACH has a Quick Ratio of 0.86. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ACH (0.84) is worse than 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.84
ACH Yearly Current Assets VS Current LiabilitesACH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

  • The earnings per share for ACH have decreased strongly by -22.29% in the last year.
  • The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
  • ACH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.09%.
  • ACH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

  • ACH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.88% yearly.
  • ACH is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -26.97% yearly.
EPS Next Y-31.69%
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%
EPS Next 5Y-0.88%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.41%
Revenue Next 5Y-26.97%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACH Yearly Revenue VS EstimatesACH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
ACH Yearly EPS VS EstimatesACH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1.80 indicates a rather cheap valuation of ACH.
  • ACH's Price/Earnings ratio is rather cheap when compared to the industry. ACH is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, ACH is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 2.45, the valuation of ACH can be described as very cheap.
  • ACH's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACH is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ACH to the average of the S&P500 Index (27.50), we can say ACH is valued rather cheaply.
Industry RankSector Rank
PE 1.8
Fwd PE 2.45
ACH Price Earnings VS Forward Price EarningsACH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ACH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACH is cheaper than 94.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.96
ACH Per share dataACH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • A cheap valuation may be justified as ACH's earnings are expected to decrease with -7.93% in the coming years.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%

0

5. Dividend

5.1 Amount

  • ACH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACCENDRA HEALTH INC

NYSE:ACH (2/4/2026, 8:04:00 PM)

After market: 2.32 0 (0%)

2.32

+0.06 (+2.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-25
Inst Owners97.53%
Inst Owner Change0%
Ins Owners3.39%
Ins Owner ChangeN/A
Market Cap179.45M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts50
Price Target3.77 (62.5%)
Short Float %12.45%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-57.22%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-39.15%
Revenue beat(4)0
Avg Revenue beat(4)-29.29%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-14.88%
Revenue beat(12)4
Avg Revenue beat(12)-9.26%
Revenue beat(16)7
Avg Revenue beat(16)-6.69%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.8
Fwd PE 2.45
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 4.96
EPS(TTM)1.29
EY55.6%
EPS(NY)0.95
Fwd EY40.81%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.71
BVpS-5.55
TBVpS-23.57
PEG (NY)N/A
PEG (5Y)0.08
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROCE 13.12%
ROIC 10.36%
ROICexc 10.59%
ROICexgc 113.35%
OM 3.07%
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)N/A
ROICexgc(3y)17.92%
ROICexgc(5y)N/A
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 105.46%
Cap/Sales 3.93%
Interest Coverage 1.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.84
Altman-Z 1.4
F-Score2
WACC6.5%
ROIC/WACC1.59
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.69%
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%
EPS Next 5Y-0.88%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.41%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year23.31%
EBIT Next 3Y6.96%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

ACCENDRA HEALTH INC / ACH FAQ

What is the fundamental rating for ACH stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACH.


Can you provide the valuation status for ACCENDRA HEALTH INC?

ChartMill assigns a valuation rating of 6 / 10 to ACCENDRA HEALTH INC (ACH). This can be considered as Fairly Valued.


What is the profitability of ACH stock?

ACCENDRA HEALTH INC (ACH) has a profitability rating of 4 / 10.


Can you provide the financial health for ACH stock?

The financial health rating of ACCENDRA HEALTH INC (ACH) is 1 / 10.


Is the dividend of ACCENDRA HEALTH INC sustainable?

The dividend rating of ACCENDRA HEALTH INC (ACH) is 0 / 10 and the dividend payout ratio is 0%.